Literature DB >> 8163714

Computer-assisted evaluation of adverse events using a Bayesian approach.

K L Lanctôt1, C A Naranjo.   

Abstract

The differential diagnosis of idiosyncratic adverse drug reactions (ADRs) is complex because for each adverse event there are many possible drug and nondrug causes. Recently efforts have been made to computerize causality assessment methods. A new computerized, user-friendly diagnostic aid for Bayesian assessment of adverse drug events (MacBARDI-Q&A) is described. This computer program performs a differential diagnosis on cutaneous reactions suspected of being drug-induced. The authors' results indicate that development of a valid, simple and user-friendly computerized procedure for evaluating adverse drug events is possible. The ongoing development and application of MacBARDI-Q&A and other similar programs should improve the evaluation of putative adverse drug reactions.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8163714     DOI: 10.1002/j.1552-4604.1994.tb03978.x

Source DB:  PubMed          Journal:  J Clin Pharmacol        ISSN: 0091-2700            Impact factor:   3.126


  10 in total

Review 1.  Modeling paradigms for medical diagnostic decision support: a survey and future directions.

Authors:  Kavishwar B Wagholikar; Vijayraghavan Sundararajan; Ashok W Deshpande
Journal:  J Med Syst       Date:  2011-10-01       Impact factor: 4.460

Review 2.  Methods for causality assessment of adverse drug reactions: a systematic review.

Authors:  Taofikat B Agbabiaka; Jelena Savović; Edzard Ernst
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

3.  Comparison of three methods (an updated logistic probabilistic method, the Naranjo and Liverpool algorithms) for the evaluation of routine pharmacovigilance case reports using consensual expert judgement as reference.

Authors:  Hélène Théophile; Manon André; Ghada Miremont-Salamé; Yannick Arimone; Bernard Bégaud
Journal:  Drug Saf       Date:  2013-10       Impact factor: 5.606

Review 4.  Pharmacovigilance in the pharmaceutical industry.

Authors:  J C Talbot; B S Nilsson
Journal:  Br J Clin Pharmacol       Date:  1998-05       Impact factor: 4.335

5.  Causal or casual? The role of causality assessment in pharmacovigilance.

Authors:  R H Meyboom; Y A Hekster; A C Egberts; F W Gribnau; I R Edwards
Journal:  Drug Saf       Date:  1997-12       Impact factor: 5.606

6.  Comparison of different methods for causality assessment of adverse drug reactions.

Authors:  Sapan Kumar Behera; Saibal Das; Alphienes Stanley Xavier; Srinivas Velupula; Selvarajan Sandhiya
Journal:  Int J Clin Pharm       Date:  2018-07-26

Review 7.  The epidemiology of serious adverse drug reactions among the elderly.

Authors:  P A Atkin; P C Veitch; E M Veitch; S J Ogle
Journal:  Drugs Aging       Date:  1999-02       Impact factor: 3.923

8.  The impact of unlicensed and off-label drug use on adverse drug reactions in paediatric patients.

Authors:  Antje Neubert; Harald Dormann; Jutta Weiss; Tobias Egger; Manfred Criegee-Rieck; Wolfgang Rascher; Kay Brune; Burkhard Hinz
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

Review 9.  Management of cutaneous drug reactions.

Authors:  K S Babu; Geeta Belgi
Journal:  Curr Allergy Asthma Rep       Date:  2002-01       Impact factor: 4.919

10.  Causality or Relatedness Assessment in Adverse Drug Reaction and Its Relevance in Dermatology.

Authors:  Sushil Pande
Journal:  Indian J Dermatol       Date:  2018 Jan-Feb       Impact factor: 1.494

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.